What is Zembrace® SymTouch®

A ready-to-use, single-use, 3 mg sumatriptan pen (auto-injector).

How can Zembrace® SymTouch® help

Zembrace® SymTouch® is indicated for the acute treatment of migraine with or without aura in adults.

If you suffer from any of the following migraines, Zembrace® SymTouch® may be able to help:

Morning
migraine

Nearly half of all migraine attacks occur between 4 and 9 a.m.3

Rapid-onset
migraine

A migraine that reaches full force quickly.

Breakthrough
migraine

If you still have migraines while on a preventive medication.

Migraine
with nausea

Up to 92% of patients have experienced nausea (with or without vomiting) during migraine attacks, according to a patient-reported survey (N=500).4

Do not use Zembrace® SymTouch® if you have: heart problems or a history of heart problems; had a stroke, transient ischemic attacks (TIAs), or problems with your blood circulation. These are not all of the reasons you should not use Zembrace® SymTouch®. See the Important Safety Information, and speak with your healthcare provider for more information about whether Zembrace® SymTouch® is right for you.

References:

  1. Brand-Schieber E, Munjal S, Kumar R, et al. Human factors validation study of 3 mg sumatriptan autoinjector, for migraine patients. Med Devices (Auckl). 2016;9:131-137.
  2. Zembrace SymTouch [package insert]. Maple Grove, MN: Upsher-Smith Laboratories, LLC: July 2019.
  3. Top 10 migraine triggers and how to deal with them. American Migraine Foundation. https://americanmigrainefoundation.org/resource-library/top-10-migraine-triggers-and-how-to-deal-with-them/. Published July 27, 2017. Accessed September 20, 2019.
  4. Silberstein S. Migraine symptoms: results of a survey of self-reportedmigraineurs. Headache. 1995;35:387-396.